Vascular Solutions Newswire

Vascular Solutions Newswire

Comprehensive Real-Time News Feed for Vascular Solutions.

Results 1 - 20 of 233 in Vascular Solutions

  1. Vascular Solutions Inc. (VASC) Reaches New 12-Month High at $47.75Read the original story w/Photo

    Saturday Aug 20 | Daily Political

    Vascular Solutions Inc. shares reached a new 52-week high during trading on Thursday . The stock traded as high as $47.75 and last traded at $47.70, with a volume of 28,117 shares traded.

    Comment?

  2. FDA Issues Draft Guidance on 'Deciding When to Submit a 510(k) for a...Read the original story w/Photo

    Friday Aug 19 | JD Supra

    ... in the 2016 guidance. Some examples appear to be based on recent court cases. For example, in the recent Vascular Solutions case , 12 , 13 the government charged Vascular Solutions, Inc., and its CEO Howard Root, with conspiracy and several counts ...

    Comment?

  3. Vascular Solutions Inc. (VASC) Sets New 52-Week High at $47.75Read the original story w/Photo

    Thursday Aug 18 | Daily Political

    Shares of Vascular Solutions Inc. reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $47.75 and last traded at $47.70, with a volume of 28,117 shares.

    Comment?

  4. Canaccord Genuity Reaffirms "Buy" Rating for Vascular Solutions Inc.Read the original story w/Photo

    Sunday Aug 14 | AmericanBankingNews.com

    Shares of Vascular Solutions traded up 0.34% during trading on Wednesday, hitting $47.18. The company's stock had a trading volume of 146,235 shares.

    Comment?

  5. Vascular Solutions Inc. (VASC) Sees Strong Trading VolumeRead the original story w/Photo

    Saturday Aug 13 | Daily Political

    Vascular Solutions Inc. saw unusually-strong trading volume on Thursday . Approximately 169,831 shares were traded during trading, an increase of 22% from the previous session's volume of 139,331 shares.The stock last traded at $47.07 and had previously closed at $47.34.

    Comment?

  6. Weekly Investment Analysts' Ratings Changes for Vascular SolutionsRead the original story w/Photo

    Friday Aug 12 | AmericanBankingNews.com

    They now have a $52.00 price target on the stock. According to Zacks, "Vascular Solutions Inc. manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty and stenting.

    Comment?

  7. Vascular Solutions Inc. (VASC) Sees Unusually-High Trading VolumeRead the original story w/Photo

    Friday Aug 12 | Daily Political

    Vascular Solutions Inc. shares saw strong trading volume on Thursday . 169,831 shares changed hands during trading, an increase of 22% from the previous session's volume of 139,331 shares.The stock last traded at $47.07 and had previously closed at $47.34.

    Comment?

  8. Vascular Solutions Inc. (VASC) Given "Buy" Rating at Canaccord GenuityRead the original story w/Photo

    Thursday Aug 11 | Daily Political

    Vascular Solutions opened at 47.34 on Wednesday. Vascular Solutions has a 1-year low of $24.34 and a 1-year high of $47.40.

    Comment?

  9. Vascular Solutions Inc. (VASC) Sets New 1-Year High at $47.40Read the original story w/Photo

    Wednesday Aug 10 | Daily Political

    Vascular Solutions Inc. hit a new 52-week high on Wednesday . The company traded as high as $47.40 and last traded at $47.34, with a volume of 74,928 shares changing hands.

    Comment?

  10. Analysts Expect Vascular Solutions Inc. (NASDAQ:VASC) to Post $0.31 EPSRead the original story w/Photo

    Wednesday Aug 10 | AmericanBankingNews.com

    Shares of Vascular Solutions Inc. have earned an average broker rating score of 2.00 from the three analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company.

    Comment?

  11. Canaccord Genuity Reaffirms "Buy" Rating for Vascular Solutions Inc.Read the original story w/Photo

    Wednesday Aug 10 | AmericanBankingNews.com

    's stock had its "buy" rating reiterated by equities researchers at Canaccord Genuity in a note issued to investors on Wednesday. In other Vascular Solutions news, CEO Howard Root sold 34,418 shares of the company's stock in a transaction dated Tuesday, May 24th.

    Comment?

  12. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    Tuesday Aug 9 | Business Wire

    ... solutions primarily focused on the healthcare industry, today announced financi... )--Howard Root, CEO of Vascular Solutions, will headline the Dorsey 4D Symposium (Dorsey 4DS) in Palo Alto with a keynote address on September 29. )--STORY, New ...

    Comment?

  13. Howard Root to Deliver Keynote at 2016 Dorsey 4D SymposiumRead the original story w/Photo

    Tuesday Aug 9 | Freshnews

    International law firm Dorsey & Whitney LLP announced today that Howard Root, CEO of Vascular Solutions, will headline the Dorsey 4D Symposium in Palo Alto with a keynote address on September 29. The symposium addresses the "4Ds" of the life sciences industry - devices, diagnostics, drugs and digital health. More information is available at dorsey4ds.com .

    Comment?

  14. Recent Analysts' Ratings Updates for Vascular SolutionsRead the original story w/Photo

    Tuesday Aug 2 | AmericanBankingNews.com

    They now have a $52.00 price target on the stock. According to Zacks, "Vascular Solutions Inc. manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and radiologists to rapidly seal the puncture site following catheterization procedures such as angiography, angioplasty and stenting.

    Comment?

  15. Zacks Investment Research Upgrades Vascular Solutions Inc. (VASC) to "Buy"Read the original story w/Photo

    Monday Aug 1 | Daily Political

    ... target price points to a potential upside of 13.36% from the stock's previous close. According to Zacks, "Vascular Solutions Inc. manufactures, markets and sells the Vascular Solutions Duett sealing device, which enables cardiologists and ...

    Comment?

  16. William Rutstein Sells 10,011 Shares of Vascular Solutions Inc. (VASC) StockRead the original story w/Photo

    Friday Jul 29 | Daily Political

    Vascular Solutions Inc. VP William Rutstein sold 10,011 shares of the firm's stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total value of $463,108.86.

    Comment?

  17. Vascular Solutions Inc. (VASC) Upgraded to "Buy" at TheStreetRead the original story w/Photo

    Thursday Jul 28 | Daily Political

    Vascular Solutions opened at 46.21 on Monday. The company has a 50-day moving average of $41.64 and a 200-day moving average of $34.56.

    Comment?

  18. Feltl & Co. Equities Analysts Cut Earnings Estimates for Vascular Solutions Inc.Read the original story w/Photo

    Wednesday Jul 27 | Daily Political

    Vascular Solutions Inc. - Equities researchers at Feltl & Co. decreased their Q3 2016 earnings estimates for Vascular Solutions in a report released on Tuesday.

    Comment?

  19. Vascular Solutions Inc. (VASC) CEO Howard Root Sells 40,000 SharesRead the original story w/Photo

    Wednesday Jul 27 | AmericanBankingNews.com

    Vascular Solutions Inc. CEO Howard Root sold 40,000 shares of the stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total transaction of $1,804,400.00.

    Comment?

  20. Vascular Solutions Inc. (VASC) Issues Quarterly Earnings ResultsRead the original story w/Photo

    Wednesday Jul 27 | Daily Political

    Vascular Solutions Inc. announced its earnings results on Monday. The medical device company reported $0.33 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.30 by $0.03.

    Comment?